Pyrazolo [1,5-alpha] pyrimidinyl derivatives useful as corticotropin-releasing factor (CRF) receptor antagonists
Details for Australian Patent Application No. 2005295353 (hide)
International Classifications
Event Publications
19 April 2007 PCT application entered the National Phase
PCT publication WO2006/044958 Priority application(s): WO2006/044958
30 October 2008 Assignment before Grant
Neurocrine Biosciences Inc.; SB Pharmco Puerto Rico Inc. The application has been assigned to Neurocrine Biosciences Inc.; SmithKline Beecham (Cork) Limited 2006
12 January 2012 Application Accepted
Published as AU-B-2005295353
10 May 2012 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2005295351-Methods for assembly of high fidelity synthetic polynucleotides
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser